September 23-26, 2024
Hynes Convention CenterBoston, USAKey Sessions
Sarah Glaven
Keynote Address from White House Office of Science and Technology Policy – TBC
White House Office of Science and Technology Policy
Thomas Kelly
When will we have a clone? An industry perspective on the typical CLD timeline
Johnson & Johnson Innovative Medicine
Niklas Engler
Next Generation Process Development and Manufacturing for Cell and Gene Therapies - Improving Efficiencies and Reducing Cost of Goods
F. Hoffmann-La Roche
Garima Thakur
Intensification of Downstream Manufacturing of Recombinant Adeno-Viral Vectors using Continuous Processing
Regeneron Pharmaceuticals
Jeffrey Baker
Flow in Biopharmaceutical Development - Enabling Capacity, Quality, and Technological Maturity
NIIMBL; Strategic Advisor, CBI-MIT
Marinna Madrid
An AI- and Laser-based Biomanufacturing Platform to Scale Production of Personalized Regenerative Cell Therapies
Cellino